Header cover image

French (CAC) Healthcare Sector Analysis

UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies80
  • 7D-0.01%
  • 3M2.9%
  • 1Y-7.6%
  • YTD-0.4%

The Healthcare is pretty flat in the last 7 days, but Sartorius Stedim Biotech has stood out, gaining 5.7%. Unfortunately though, the industry is down 7.6% over the past 12 months. Looking forward, earnings are forecast to grow by 11% annually.

Sector Valuation and Performance

Has the French Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 03 Feb 2023€265.0b€104.9b€10.5b18.3x25.2x2.5x
Sun, 01 Jan 2023€265.5b€104.9b€10.5b17.6x25.3x2.5x
Tue, 29 Nov 2022€268.8b€105.1b€10.5b17.8x25.7x2.6x
Thu, 27 Oct 2022€257.1b€102.5b€10.4b17.8x24.8x2.5x
Sat, 24 Sep 2022€173.6b€79.3b€9.0b17.1x19.3x2.2x
Mon, 22 Aug 2022€193.2b€78.9b€9.0b20.7x21.4x2.4x
Wed, 20 Jul 2022€212.2b€76.6b€9.1b20.3x23.4x2.8x
Fri, 17 Jun 2022€193.4b€76.4b€9.2b18.1x21x2.5x
Sun, 15 May 2022€207.9b€75.5b€9.3b18.7x22.4x2.8x
Tue, 12 Apr 2022€227.5b€74.4b€8.8b20.3x25.9x3.1x
Thu, 10 Mar 2022€203.4b€73.7b€8.5b19x23.9x2.8x
Sat, 05 Feb 2022€207.3b€71.8b€8.5b18.4x24.3x2.9x
Mon, 03 Jan 2022€226.7b€71.8b€8.5b24.4x26.6x3.2x
Wed, 01 Dec 2021€225.6b€71.8b€8.5b22.1x26.5x3.1x
Fri, 29 Oct 2021€221.4b€70.8b€8.1b23.9x27.2x3.1x
Sun, 26 Sep 2021€222.6b€70.5b€8.1b26.4x27.4x3.2x
Tue, 24 Aug 2021€230.1b€70.2b€8.1b26.1x28.4x3.3x
Wed, 30 Jun 2021€212.5b€70.2b€8.1b26.6x26.3x3x
Sat, 03 Apr 2021€199.0b€68.5b€14.2b28.3x14x2.9x
Tue, 05 Jan 2021€185.4b€67.9b€14.0b28.1x13.2x2.7x
Fri, 09 Oct 2020€192.7b€67.2b€12.3b33.2x15.6x2.9x
Thu, 02 Jul 2020€187.8b€66.3b€11.7b36.2x16.1x2.8x
Sun, 05 Apr 2020€160.6b€66.6b€4.0b28.5x40.6x2.4x
Price to Earnings Ratio

52x


Total Market Cap: €172.8bTotal Earnings: €3.3bTotal Revenue: €65.7bTotal Market Cap vs Earnings and Revenue0%0%0%
French Healthcare Sector Price to Earnings3Y Average 23.8x202120222023
Current Industry PE
  • Investors are relatively neutral on the French Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 23.8x.
  • The industry is trading close to its 3-year average PS ratio of 2.8x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 47% per year over the last three years.
  • Revenues for these companies have grown 17% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the French Healthcare sector?

FR Market1.14%
Healthcare-0.012%
Life Sciences5.83%
Biotech2.27%
Medical Equipment1.43%
Healthtech1.12%
Pharma-2.96%
Healthcare Services-3.94%
Industry PE
  • Investors are most optimistic about the Medical Equipment industry, which is trading close to its 3-year average PE ratio of 37.9x.
    • Analysts are expecting annual earnings growth of 11.0%, which is higher than its past year's earnings growth of 8.5% per year.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 32% over the next 5 years.
  • However this is lower than its past earnings growth rate of 43% per year.
  • In contrast, the Life Sciences industry is expected to see its earnings grow by 6.8% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
DIM Sartorius Stedim Biotech€346.405.7%
+€1.7b
-10.2%PE46.9x
EL EssilorLuxottica Société anonyme€170.751.7%
+€1.3b
-0.7%PE42.6x
ERF Eurofins Scientific€68.986.2%
+€773.8m
-23.2%PE20.7x
EAPI Euroapi€15.5212.5%
+€162.6m
n/aPE729.3x
VIRP Virbac€284.003.3%
+€76.1m
-18.5%PE20.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SAN

€86.77

Sanofi

7D

-3.3%

1Y

-5.0%

BIM

€95.98

bioMérieux

7D

-0.3%

1Y

-6.5%

ORP

€3.75

Orpea

7D

-47.0%

1Y

-90.3%

DIM

€346.40

Sartorius Stedim Biotech

7D

5.7%

1Y

-10.2%

IPN

€97.10

Ipsen

7D

-2.7%

1Y

8.6%

AB

€6.31

AB Science

7D

-4.0%

1Y

-32.7%

OSE

€6.01

OSE Immunotherapeutics

7D

-7.2%

1Y

-29.2%

VIRP

€284.00

Virbac

7D

3.3%

1Y

-18.5%